Current Report Filing (8-k)
16 January 2018 - 10:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE
SECURITIES EXCHANGE ACT OF 1934
DATE OF
REPORT (DATE OF EARLIEST EVENT REPORTED): January 12, 2018
Corix Bioscience, Inc.
(EXACT NAME OF REGISTRANT AS SPECIFIED
IN CHARTER)
|
|
|
|
|
Wyoming
|
|
333-150548
|
|
75-3265854
|
(STATE OR OTHER JURISDICTION
OF INCORPORATION OR ORGANIZATION)
|
|
(COMMISSION FILE NO.)
|
|
(IRS EMPLOYEE IDENTIFICATION NO.)
|
16772 West Bell Road, Suite 110-471
in Surprise, Arizona 85374
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES)
18662 MacAurther Boulevard, Suite
200 in Irvine, California 92612
(ADDRESS OF FORMER PRINCIPAL EXECUTIVE
OFFICES)
34225 N. 27
th
Drive, Building
5, Suite 238 in Phoenix, Arizona 85085
(ADDRESS OF FORMER PRINCIPAL EXECUTIVE
OFFICES)
(623) 551-5808
(ISSUER TELEPHONE NUMBER)
Check the appropriate box below if the Form 8-K filing is
intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General
Instruction A.2. below):
¨
|
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter.
☒
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☒
SECTION 8 – OTHER EVENTS
Item 8.01 Other Events
On January 10, 2018, American Housing
Income Trust, Inc. (the “Company”) issued a press release titled “Corix Responds to Minority Shareholder’s
Lawsuit.” The purpose of the release is to announce the Company’s defense of a lawsuit initiated by a minority shareholder
named George Sharp.
SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits
Exhibit No.
|
Document
|
|
|
99.1
|
Press Release dated January 10, 2018
|
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto
duly authorized.
Corix Bioscience, Inc.
By:
/s/
Michael Ogburn
Name: Michael Ogburn
Title: Chief Executive Officer and President
Dated: January 12, 2018
Corix Bioscience (CE) (USOTC:CXBS)
Historical Stock Chart
From Apr 2024 to May 2024
Corix Bioscience (CE) (USOTC:CXBS)
Historical Stock Chart
From May 2023 to May 2024